Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI).

NCT ID: NCT02202538

Last Updated: 2017-07-25

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

53 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-08-31

Study Completion Date

2015-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the Indego® device for safety and effectiveness at allowing persons with SCI who are non-ambulatory or poorly ambulatory to stand up and walk under a variety of conditions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Cord Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Indego

Indego

Group Type EXPERIMENTAL

Indego

Intervention Type DEVICE

Indego

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Indego

Indego

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Be 18 years or older
* Height 5'1" to 6'3" (Acceptable height may vary by a few inches depending on femur length).
* Hip width as measured in sitting no greater than 16.6" (42 cm) (acceptable hip width may vary depending on soft tissue).
* Femur length as measured in sitting must be between 14 inches (35.5cm) and 18.5 inches (47 cm)
* Weight 250lbs (113.4 kg) or less
* Present with Spinal Cord Injury and NLI C5 and lower, with ISNCSCI A, B, C or D who are non-ambulatory or poorly ambulatory.
* There are no restrictions on time since injury. However, each subject must have signed medical clearance/approval for full weight bearing and locomotor training.
* Determined to have sufficient bone health for walking with full weight bearing without undue risk for fracture. Meeting of this criterion is at the discretion of each subject's personal MD and must be approved by each site's Medical PI.
* Passive range of motion (PROM) at shoulders, trunk, upper extremities and lower extremities within functional limits for safe gait and use of appropriate assistive device/stability aid.
* Skin must be intact where it interfaces with robotic device
* Modified Ashworth Scale for spasticity score must be 3 or less.
* Blood pressure and heart rate within established guidelines for locomotor training:

* At rest; Systolic 150 or less Diastolic 90 or less and Heart rate 105 or less
* Exercise; Systolic 180 or less Diastolic 105 or less and Heart Rate 145 or less
* Tolerate being in an upright standing position (passive or active) without being lightheaded or having a headache.

Exclusion Criteria

* Weight in excess of 250 lbs
* Heterotopic ossification that, in the opinion of the investigator, would place the subject at undue risk for fracture.
* Any subject deemed at increased risk for injury by Medical Personnel
* Lower extremity joint limitation that exceeds 10 degrees at their hips, knees or ankles.
* Light headedness or headache in standing position (active or passive)
* Moderate to Severe Traumatic (or Acquired) Brain Injury
* Inability to follow instructions
* Colostomy bag
* Women who are pregnant or attempting to become pregnant during the study intervention.
* Unable to obtain informed consent (either from the subject or from the subjects Legally Authorized Representative).
* Any disease, concomitant injury, or condition that interferes with the performance or interpretation of the protocol specified assessments
* Unlikely to be available for follow-up phone call.
* Any other issue which, in the opinion of the investigators, will make the subject unsuitable for study participation.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Parker Hannifin Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Craig Hospital

Englewood, Colorado, United States

Site Status

Shepherd Center

Atlanta, Georgia, United States

Site Status

Rehabilitation Institue of Chicago

Chicago, Illinois, United States

Site Status

Kessler Institute for Rehabilitation

West Orange, New Jersey, United States

Site Status

RUSK Rehabilitation Center

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PH-IND01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phoenix Exoskeleton for SCI Users
NCT03175055 COMPLETED NA
Exoskeleton and Spinal Cord Injury
NCT03410550 COMPLETED PHASE2